Generic Versions of Zocor Approved

2nd-best selling cholesterol drug in U.S.

Please note: This article was published more than one year ago. The facts and conclusions presented may have since changed and may no longer be accurate. And "More information" links may no longer work. Questions about personal health should always be referred to a physician or other health care professional.

FRIDAY, June 23, 2006 (HealthDay News) -- The first generic versions of the anti-cholesterol drug Zocor (simvastatin) were approved Friday by the U.S. Food and Drug Administration.

Zocor, made by Merck & Co., is the 2nd-best selling statin drug in the United States behind Pfizer's Lipitor. Statins, designed to control high cholesterol and other fatty substances in the blood, accounted for $16 billion in U.S. sales last year, the FDA said in a statement.

Even though generic versions of Zocor will be available, the drugs will still require a prescription.

Generic simvastatin in 5 mg. 10 mg., 20 mg., and 40 mg. doses will be produced by IVAX Pharmaceuticals Inc., of Northvale, N.J.

An 80 mg. dose of the drug will be made by Ranbaxy Pharmaceuticals Inc. of Princeton, N.J., the agency said.

Merck's patent on the drug expired Friday.

More information

To learn more about high cholesterol, visit the U.S. National Heart, Lung, and Blood Institute.

--

Last Updated: